FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/24/2025
Back to search
Official data from USPTO
ZYTOLIGHT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
04/03/2026
Trademark type
Word
Nice classes
5
Filing date
10/12/2023
Registration date
12/03/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/03/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
BECKER, MARY ELIZABETH
Law office
L30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
ZytoVision GmbH
Representatives
Laurence P. Colton SMITH TEMPEL BLAHA LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical and veterinary preparations and articles in the nature of medical diagnostic reagents for diagnosis of genetic disorders and genetic aberrations in tumors; diagnostic preparations for medical use; diagnostic preparations for veterinary use; biological preparations for medical purposesDNARNA and oligonucleotide probesbeing biochemical reagentscomposed of biochemical substancesoligonucleotidesproteins and enzymes and antibodiesall for medical diagnostic purposesall for the treatment of genetic disorders and genetic aberrations in tumors; biological preparations for veterinary purposesDNARNA and oligonucleotide probesbeing biochemical reagentscomposed of biochemical substancesoligonucleotidesproteins and enzymes and antibodiesall for veterinary diagnostic purposesall for the treatment of genetic disorders and genetic aberrations in tumors; chemical preparations for medical purposesDNA probesRNA probes and oligonucleotide probesall being biochemical reagents composed of polynucleotidesbiochemical substancesoligonucleotidesproteins and enzymes and antibodiesall for diagnosis of genetic disorders and genetic aberrations in tumors; chemical preparations for veterinary purposesDNA probesRNA probes and oligonucleotide probesall being biochemical reagents composed of polynucleotidesbiochemical substancesoligonucleotidesproteins and enzymes and antibodiesall for diagnosis of genetic disorders and genetic aberrations in tumors; diagnostic chemical reagents for medical use; chemical preparations for testing blood for blood disorderstumor diseasesvirusesbacteriadisease diagnosis and detectionorgan functionmetabolic disordersendocrine disordershormonal disordersbacteria-based disordersvirus-based disordersfungal infections for medical purposes; chemical preparations for use in DNA analysis for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic chemical test reagents for medical purposes; diagnostic chemical test reagents for veterinary purposes; diagnostic agents for pharmaceutical use; diagnostic testing materials in the nature of diagnostic chemical and biological reagents for medical use; indicators for medical diagnosis in the nature of chemical and biological diagnostic reagents; clinical medical reagents; diagnostic reagents for medical use; reagents for use in diagnostic analysis for veterinary purposes; reagents for analytical diagnostic purposes for medical purposes; reagents for analytical diagnostic purposes for veterinary purposes; diagnostic reagents for in-vitro laboratory use for medical purposes; diagnostic reagents for in-vitro laboratory use for veterinary purposes; reagents for use in diagnostic tests for veterinary purposes; diagnostic reagents for microbiological analysis for medical purposes; diagnostic reagents for microbiological analysis for veterinary purposes; reagents for use in diagnostic analysis for medical purposes; reagents for use in diagnostic tests for medical purposes; diagnostic reagents for use with analyzers for veterinary purposes; diagnostic reagents for use with analyzers for medical purposes; reactants for medical diagnosis; reactants for veterinary diagnosis; veterinary diagnostic reagents
Publications
History of USPTO decisions and trademark events.
30 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/06/2025
FIMP
FINAL DISPOSITION PROCESSED
05/06/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/26/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/08/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/08/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/03/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/03/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/03/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/01/2024
PUBO
PUBLISHED FOR OPPOSITION
10/01/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/11/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/29/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
08/29/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/29/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
08/29/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/29/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/22/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/22/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/22/2024
RFNT
REFUSAL PROCESSED BY IB
07/27/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/25/2024
RFRR
REFUSAL PROCESSED BY MPU
06/25/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/14/2024
CNRT
NON-FINAL ACTION WRITTEN
05/30/2024
DOCK
ASSIGNED TO EXAMINER
05/30/2024
MAFR
APPLICATION FILING RECEIPT MAILED
11/21/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/17/2023
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
11/14/2023
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
11/09/2023
Continuous trademark protection
Get notified about every new filing that threatens ZYTOLIGHT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.